Effects of taurine on the reactivity of aortas from diabetic rats

Life Sciences

Volumn 82, Issue 5-6, 2008, Pages 279-289

  Abebe, Worku ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Aorta; Diabetic rat; Strepotozoticin; Taurine; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; CALCIUM; NORADRENALIN; PHENYLEPHRINE; PROTEIN KINASE C; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENDOTHELIUM CELL; HYPERGLYCEMIA; MALE; NONHUMAN; RAT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; GLUCOSE; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; PHENYLEPHRINE; PROTEIN KINASE C; RATS; RATS, INBRED WKY; TAURINE;

RATTUS;

EID: 38349061444     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.11.012     Document Type: Article

References (61)

1. Abebe W., and MacLeod K.M. Protein kinase C-mediated contractile responses of arteries from diabetic rats. British Journal of Pharmacology 101 (1990) 465-473
2. Abebe W., and MacLeod K.M. Enhanced arterial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism. Canadian Journal of Physiology and Pharmacology 69 (1991) 355-361
3. Abebe W., and MacLeod K.M. Influences of diabetes on noradrenaline-induced inositol 1,4,5-trisphosphate levels in rat aorta. Life Sciences 49 (1991) PL-85-PL90
4. Abebe W., and MacLeod K.M. Augmented inositol phosphate production in mesenteric arteries from diabetic rats. European Journal of Pharmacology 225 (1992) 29-34
5. Abebe W., and Mozaffari M.S. Effect of chronic taurine treatment on reactivity of rat aorta. Amino Acids 19 (2000) 615-623
6. Abebe W., and Mozaffari M.S. Taurine depletion alters vascular reactivity in rats. Canadian Journal of Physiology and Pharmacology 81 (2003) 903-909
7. Abebe W., and Mozaffari M.S. Effect of taurine deficiency on adenosine receptor-mediated relaxation of the rat aorta. Vascular Pharmacology 40 (2003) 219-228
8. 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. Journal of Cardiovascular Pharmacology 16 (1990) 239-248
9. Abebe W., Cavallari N., Agrawal D.K., Rowley J., Hunter W.J., and Edwards J.D. Functional and morphological assessment of rat aorta stored in University of Wisconsin and Eurocollins solution. Transplantation 56 (1993) 808-816
10. Abebe W., Harris K.H., and MacLeod K.M. Role of extracellular calcium in the selective enhancement of contractile responses of arteries from diabetic rats to noradrenaline. Canadian Journal of Physiology and Pharmacology 72 (1994) 1544-1551
11. Agrawal D.K., and McNeill J.H. Vascular responses to agonists in rat mesenteric artery from diabetic rats. Canadian Journal of Physiology and Pharmacology 65 (1987) 484-1491
12. Altan V.M., Karasru C., and Ozuari A. The effects of type 1 and type 2 diabetes on endothelium-dependent relaxation in rat aorta. Pharmacology, Biochemistry and Behavior 33 (1989) 519-522
13. Anuradha C.V., and Balakrishnan S.D. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Canadian Journal of Physiology and Pharmacology 77 (1999) 749-754
14. Belay T., and Cohen R.C. Free radical mediated endothelial cell dysfunction cause by elevated glucose. American Journal of Physiology 263 (1992) H321-H326
15. + transport by taurine in heart and vascular smooth muscle. Advances in Experimental Medicine and Biology 403 (1996) 263-273
16. Casey R.G., Joyce C.G., and Hayes D.J.B. Taurine attenuates acute hyperglycemia-induced endothelial cell apoptosis, leucocyte-endothlial cell interactions and cardiac dysfunction. Journal of Vascular Research 44 (2007) 31-39
17. Chang K.S.K., and Stevens C.W. Endothelium-dependent increases in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. British Journal of Pharmacology 107 (1992) 983-990
18. Cooper M.E., Bonnet F., Oldfield M., and Jandeleit-Dahm K. Mechanisms of diabetic vasculopathy: an overview. American Journal of Hypertension 14 (2001) 475-486
19. De-Vries D.S., Verbeuren T.J., Van de Voorde J., Lameire N.H., and Vanhoutee P.M. Endothelial dysfunction in diabetes. British Journal of Pharmacology 130 (2000) 963-974
20. Fahim M., Hussain T., and Mustafa S.J. Relaxation of rat aorta by adenosine in diabetes with and without hypertension: role of endothelium. European Journal of Pharmacology 412 (2001) 51-59
21. Fennessy E.M., Monelet M.B., Wang J.H., Kelly C.J., and Bouchier-Hayes D.J. Taurine and Vitamin C modify monocyte and endothelial dysfunction in young smokers. Circulation 107 (2003) 410-415
22. 2+ distribution. Diabetes 48 (1999) 1323-1330
23. Franconi F., Giotti A., Manzini S., Martini F., Stendardi I., and Zilliti L. The effect of taurine on high potassium- and noradrenaline-induced contraction in rabbit ear artery. British Journal of Pharmacology 75 (1982) 605-612
24. Ha H., Yu M.R., Choi Y.J., and Lee H.B. Activation of protein kinase C-δ and C-e{open} by oxidative stress in early diabetic rat kidney. American Journal of Kidney Diseases 38 Suppl. 4 (1996) S204-S207
25. Hagiwara K., Kuroki G., Yuan P.X., et al. The effect of taurine on the salt-dependent blood pressure increase in the voltage-dependent calcium channel β3-subunit-defecient mouse. Journal of Cardiovascular Pharmacology 41 (2003) S127-S131
26. Hamaguchi T., Azuma J., and Schaffer S. Interaction of taurine with methionine: inhibition of myocardial phospholipid methyltransferase. Journal of Cardiovascular Pharmacology 18 (1991) 224-230
27. Hansen S.H. The role of taurine in diabetes and the development of diabetes complications. Diabetes Metabolism Research and Reviews 17 (2001) 330-346
28. Harris K.H., and MacLeod K.M. Influence of the endothelium on contractile response of arteries from diabetic rats. European Journal of Pharmacology 153 (1988) 55-65
29. Hashim S., Li Y., and Anand-srivastava M.B. G protein-linked cell signaling and cardiovascular functions in diabetes/hyperglycemia. Cell Biochemistry and Biophysics 44 (2006) 51-64
30. Hopfner R.L., McNeill J.R., and Gopalakrishnanan V. Plasma endothelin levels and vascular responses at different temporal stages of streptozotocin diabetes. European Journal of Pharmacology 374 (1999) 221-227
31. Huxtable R.J. The interaction between taurine, calcium and phospholipids: further investigations of a trinitarian hypothesis. In: Pasantes-Morales H., Shain W., Martin D.L., and Martin del Rio R. (Eds). Taurine:Functional Neurochemistry Physiology, and Cardiology (1990), Wiley-Liss, New York, NY 185-196
32. Huxtable R.J. Physiological actions of taurine. Physiological Reviews 72 (1992) 101-163
33. Ihnat M.A., Thorpe J.E., Kamat C.D., shakir S., Kaltreider R.C., and Ceriello A. Reactive oxygen species mediate a cellular 'memory' of high glucose stress signaling. Diabetologia 50 (2007) 1523-1531
34. Katama K., sugiura M., Kojima S., and Kasuya Y. Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine. European Journal of Pharmacology 303 (1996) 47-53
35. Korang K., Milakofsky L., Hare T.A., Hofford J.M., and Vogel W.H. Levels of taurine, amino acids and related compounds in plasma, vena cava, aorta and heart of rats after taurine administration. Pharmacology 52 (1996) 263-270
36. Laakso M. Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes. Primary Care 26 (1999) 829-839
37. Li N., Sawamura M., Nara Y., Ikeda K., and Yamori Y. Direct inhibitory effects of taurine on norepinephrine-induced contraction in mesenteric artery of stroke-prone spontaneously hypertensive rats. Advances in Experimental and Medical Biology 403 (1996) 257-262
38. Longhurt P.A., and Head R.J. Responses of isolated perfused mesenteric vasculature from diabetic rats: the significance of appropriate control tissues. Journal of Pharmacology and Experimental Therapeutics 235 (1985) 45-52
39. MacLeod K.M. The effect of insulin treatment on changes in vascular reactivity in chronic, experimental diabetes. Diabetes 34 (1985) 1160-1167
40. McCarty M.F. Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate. Medical Hypothesis 46 (1996) 89-100
41. Militante J.D., Lombardini J.B., and Schaffer S.W. The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus. Cardiovascular Research 46 (2000) 393-402
42. Mueed I., Zhang L., and MacLeod K.M. Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to α-adrenoceptor stimulation. British Journal of Pharmacology 146 (2005) 972-982
43. Nagareddy P., Xia Z., MacLeod K.M., and McNeill J.H. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats. Journal of Cardiovascular Pharmacololgy 47 (2006) 513-520
44. Nandhini T.A., and Anuradha C.V. Inhibition of lipid peroxidation, protein glycation and elevation of membrane ion pump activity by taurine in RBC exposed to high glucose. Clinica Chimica Acta 336 (2003) 129-135
45. Ozkan M.H., and Uma S. Inhibition of acetylcholine-induced EDHF response by elevated glucose in mesenteric artery. Life Sciences 78 (2005) 14-21
46. Ristori M.T., and Verdetti J. Effects of taurine on rat aorta in vitro. Fundamentals of Clinical Pharmacology 5 (1991) 245-258
47. Roy S., Sala R., Cagliero E., and Lorenzi M. Over expression of fibronectin induced by diabetes or high glucose: phenomenon with memory. Proceedings of the National Academy of Sciences 87 (1990) 404-408
48. Roysommuti S., Azuma J., Takahashi K., and Schaffer S. Taurine cytoprotection: from cell to system. Thai Journal of Physiological Society 16 (2003) 17-27
49. Ruderman N.B., Williamson J.R., and Brownlee M. Glucose and diabetic vascular disease. FASEB Journal 6 (1992) 2905-2914
50. Schaffer S.W., Kramer J., and Chovan J.P. Regulation of calcium homeostasis in the heart by taurine. Federation Proceedings 39 (1980) 2691-2694
51. Studer R.K., Craven P.A., and DeRubertis F.R. Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 46 (1997) 918-925
52. Subramanian R., and MacLeod K.M. Vascular reactivity in streptozotocin-induced diabetes. In: McNeill J.H. (Ed). Experimental Models of Diabetes (1999), CRC Press, Boca Raton, FL 153-175
53. Taylor P.D., and Poston L. The effect of hyperglycemia on the function of rat mesenteric resistance artery. British Journal of Pharmacology 113 (1994) 801-808
54. Taylor P.D., McCarthy A.L., Thomas C.R., and Poston L. Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats. British Journal of Pharmacology 107 (1992) 393-399
55. Tomlinson K.C., Gardiner S.M., Hebden R.A., and Bennett T. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacological Reviews 44 (1992) 103-150
56. Trachtman H., Futterweit S., and Bienkowski R.S. Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochemical and Biophysical Research Communications 191 (1993) 759-765
57. UK prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS3). Lancet 352 (1998) 837-853
58. Wakabayashi I., Hakati K., and Nagai K. Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sciences 40 (1987) 643-651
59. Wang J.H., Redmond H.P., and Hayes D.B. The beneficial effect of taurine on the prevention of human endothelial cell death. Shock 6 (1996) 331-338
60. Wei M., Ong L., Smith M.T., Ross F.B., Schmid K., Hoey A.J., Burstow D., and Brown L. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart, Lung and Circulation 12 (2003) 44-50
61. Wu Q.D., Wang J.H., Fennessy F., Redmond H.P., and Hayes D.B. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. American Journal of Physiology 277 (1999) C1229-C1238